Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $13,589,323,339.00 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.5524
Revenue (TTM): $0.03 M
Dividend Yield: N/A%
ROE: -8.05%
Latest News
-
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million?
Thu, Dec 18, 2025 7:55 AM
-
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF
Wed, Dec 17, 2025 12:29 PM
-
US High Growth Tech Stocks To Watch December 2025
Wed, Dec 17, 2025 11:38 AM
-
Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402 - Has The Bull Case Changed?
Mon, Dec 15, 2025 7:09 PM
-
Tracking David Einhorn's Greenlight Capital Portfolio - Q3 2025 Update
Sun, Dec 14, 2025 11:48 PM
Key Financials
Financial data not available
